A Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (Vaccine FP-01.1) in Healthy Volunteers Following Virus Challenge

Trial Profile

A Randomised, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (Vaccine FP-01.1) in Healthy Volunteers Following Virus Challenge

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs FP 01-Immune Targeting Systems (Primary)
  • Indications Influenza A virus infections
  • Focus Adverse reactions
  • Sponsors Immune Targeting Systems
  • Most Recent Events

    • 04 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 29 May 2014 Status changed from recruiting to active, no longer recruiting; according to ClinicalTrials.gov record.
    • 04 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top